Treatment of peyronie’s disease with combination of clostridium histolyticum collagenase and penile traction therapy: a prospective, multicenter, single-arm study

[1]  L. Trost,et al.  Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial. , 2019, The Journal of urology.

[2]  A. Greenstein,et al.  Penile size in adult men—recommendations for clinical and research measurements , 2019, International Journal of Impotence Research.

[3]  M. Alom,et al.  Efficacy of Combined Collagenase Clostridium histolyticum and RestoreX Penile Traction Therapy in Men with Peyronie's Disease. , 2019, The journal of sexual medicine.

[4]  L. Trost,et al.  Penile Traction Therapy and Vacuum Erection Devices in Peyronie's Disease. , 2019, Sexual medicine reviews.

[5]  H. Porst,et al.  Penile traction therapy with the new device ‘Penimaster PRO’ is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study , 2018, BJU international.

[6]  F. Sessa,et al.  Collagenase clostridium histolyticum for the treatment of Peyronie's disease: a prospective Italian multicentric study , 2018, Andrology.

[7]  A. Salonia,et al.  Predictors of treatment success after collagenase Clostridium histolyticum injection for Peyronie's disease: development of a nomogram from a multicentre single‐arm, non‐placebo controlled clinical study , 2018, BJU international.

[8]  Timerbulatov Mv,et al.  [Classification of surgical complications]. , 2018, Khirurgiia.

[9]  M. Falcone,et al.  Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol , 2017, BJU international.

[10]  M. Capece,et al.  Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease-A Review of the Literature and a New Modified Protocol. , 2017, Sexual medicine reviews.

[11]  L. Trost,et al.  Clinical Experience With Penile Traction Therapy Among Men Undergoing Collagenase Clostridium histolyticum for Peyronie Disease. , 2017, Urology.

[12]  W. Hellstrom,et al.  Impact of Number of Cycles of Collagenase Clostridium Histolyticum on Outcomes in Patients With Peyronie's Disease. , 2016, Urology.

[13]  N. Al-hathal,et al.  Peyronie’s disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up , 2016, Translational andrology and urology.

[14]  L. Trost,et al.  Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease. , 2016, The Journal of urology.

[15]  M. Pinsky,et al.  Therapeutic advances in the treatment of Peyronie's disease , 2015, Andrology.

[16]  L. Levine,et al.  Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study. , 2015, The journal of sexual medicine.

[17]  J. Carballido,et al.  Acute phase Peyronie's disease management with traction device: a nonrandomized prospective controlled trial with ultrasound correlation. , 2014, The journal of sexual medicine.

[18]  D. Ralph,et al.  Re: clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. , 2014, European urology.

[19]  A. Kadıoğlu,et al.  The pathophysiology of Peyronie’s disease , 2013, Arab journal of urology.

[20]  I. Goldstein,et al.  Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. , 2013, The Journal of urology.

[21]  L. Levine.  Peyronie’s disease: A contemporary review of non-surgical treatment , 2013, Arab journal of urology.

[22]  L. Levine,et al.  Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease. , 2012, The journal of sexual medicine.

[23]  K. McVary.  Rebuttal from Authors re: Laurence A. Levine. Seeking Answers on the Quest for Effective Nonsurgical Treatment of Peyronie's Disease. Eur Urol 2007;51:601–3 , 2007 .

[24]  L. Levine.  Seeking answers on the quest for effective nonsurgical treatment of Peyronie's disease. , 2007, European urology.

[25]  W. Steers,et al.  Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease. , 2007, European urology.

[26]  H. Eid,et al.  The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction , 2007, International Journal of Impotence Research.

[27]  L. Levine,et al.  Peyronie's Disease. , 2004, The Urologic clinics of North America.

[28]  W. Hellstrom,et al.  Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease. , 2006, The Journal of urology.

[29]  J. Marinković,et al.  Risk factors for Peyronie's disease: a case‐control study , 2006, BJU international.

[30]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[31]  A. Kadıoğlu,et al.  A retrospective review of 307 men with Peyronie's disease. , 2002, The Journal of urology.

[32]  A. Natali,et al.  Peyronie’s Disease: Prevalence and Association with Cigarette Smoking , 2001, European Urology.

[33]  T. H. Klotz,et al.  The prevalence of Peyronie's disease: results of a large survey , 2001, BJU international.

[34]  A. Natali,et al.  Peyronie's disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50-69 years. , 2001, European urology.

[35]  J. Cappelleri,et al.  Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction , 1999, International Journal of Impotence Research.

[36]  G. Brandes,et al.  The Palmar Fascia after Treatment by the Continuous Extension Technique for Dupuytren’s Contracture , 1994, Journal of hand surgery.

[37]  P. Grambsch,et al.  The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. , 1991, The Journal of urology.

[38]  A. Kelâmi.  Classification of congenital and acquired penile deviation. , 1983, Urologia internationalis.